The Third Edition of this successful textbook has been completely updated
throughout and includes new chapters on electrophysiological tests, biological
markers, global staging measures, and management of neuropsychiatric symptoms.
There has been steady progress in our understanding of the natural history,
prognostic factors and treatments for Alzheimer's disease since the previous
edition of this textbook was published in 1999. The chapters deal with the full
spectrum of populations at risk, persons in prodromal stages, and patients from
mild to severe and even terminal stages. The contributors are opinion leaders
from North America and Europe, which gives the book an internationally balanced
outlook. This new edition will be essential